Phase I clinical study of NMK36: a new PET tracer with the synthetic amino acid analogue anti-[18F]FACBC.
Asano Y, Inoue Y, Ikeda Y, Kikuchi K, Hara T, Taguchi C, Tokushige T, Maruo H, Takeda T, Nakamura T, Fujita T, Kumagai Y, Hayakawa K.
Asano Y, et al. Among authors: hayakawa k.
Ann Nucl Med. 2011 Jul;25(6):414-8. doi: 10.1007/s12149-011-0477-z. Epub 2011 Mar 16.
Ann Nucl Med. 2011.
PMID: 21409348
Clinical Trial.